Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mascha Binder

Showing results (11-20 of 168) with videos related to

Pageof 17
Sort By:
Forschende Komplementarmedizin Und Klassische Naturheilkunde = Research in Complementary and Natural Classical Medicine|October 19, 2005
The effects of a 45x potency of arsenicum album on wheat seedling growth -- a reproduction trialMascha Binder, Stephan Baumgartner, André Thurneysen
Deutsche Medizinische Wochenschrift (1946)|April 22, 2025
[Malignant melanoma]Mascha Binder, Michael von Bergwelt-Baildon
Deutsche Medizinische Wochenschrift (1946)|July 17, 2019
[Monoclonal Gammopathy Of Unknown Significance - A Common Incidental Finding - What is to be thought of? What has to be done?]Aneta Schieferdecker, Mascha Binder, Katja Weisel, et al.
Journal of Hematology & Oncology|October 19, 2017
The role of B cell antigen receptors in mantle cell lymphomaMichael Fichtner, Martin Dreyling, Mascha Binder, et al.
Translational Cancer Research|July 14, 2026
Toward precision immunotherapy in recurrent/metastatic head and neck squamous cell carcinoma: lessons from the FOCUS trialChristoph Schultheiss, Tobias Andermatt, Anna Brandt, et al.
Seminars in Immunopathology|April 29, 2022
B cells in autoimmune hepatitis: bystanders or central players?Christoph Schultheiß, Silja Steinmann, Ansgar W Lohse, et al.
Blood|May 18, 2006
The epitope recognized by rituximabMascha Binder, Florian Otto, Roland Mertelsmann, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 9, 2026
Cell Therapies and Bispecific Engagers: Redefining Strategies Against Checkpoint ResistanceHeinz Läubli, David König, Marco Donia, et al.
Cancers|April 13, 2023
Circulating Tumor DNA in Head and Neck Squamous Cell CarcinomaAnna Brandt, Benjamin Thiele, Christoph Schultheiß, et al.
Frontiers in Oncology|October 12, 2020
Targeting the Mutational Landscape of Bystander Cells: Drug-Promoted Blood Cancer From High-Prevalence Pre-neoplasias in Patients on BRAF InhibitorsDonjete Simnica, Harald Ittrich, Carsten Bockemeyer, et al.
Pageof 17

Showing results (11-20 of 168) with videos related to

Sort By:
Pageof 17
Forschende Komplementarmedizin Und Klassische Naturheilkunde = Research in Complementary and Natural Classical Medicine|October 19, 2005
The effects of a 45x potency of arsenicum album on wheat seedling growth -- a reproduction trialMascha Binder, Stephan Baumgartner, André Thurneysen
Deutsche Medizinische Wochenschrift (1946)|April 22, 2025
[Malignant melanoma]Mascha Binder, Michael von Bergwelt-Baildon
Deutsche Medizinische Wochenschrift (1946)|July 17, 2019
[Monoclonal Gammopathy Of Unknown Significance - A Common Incidental Finding - What is to be thought of? What has to be done?]Aneta Schieferdecker, Mascha Binder, Katja Weisel, et al.
Journal of Hematology & Oncology|October 19, 2017
The role of B cell antigen receptors in mantle cell lymphomaMichael Fichtner, Martin Dreyling, Mascha Binder, et al.
Translational Cancer Research|July 14, 2026
Toward precision immunotherapy in recurrent/metastatic head and neck squamous cell carcinoma: lessons from the FOCUS trialChristoph Schultheiss, Tobias Andermatt, Anna Brandt, et al.
Seminars in Immunopathology|April 29, 2022
B cells in autoimmune hepatitis: bystanders or central players?Christoph Schultheiß, Silja Steinmann, Ansgar W Lohse, et al.
Blood|May 18, 2006
The epitope recognized by rituximabMascha Binder, Florian Otto, Roland Mertelsmann, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 9, 2026
Cell Therapies and Bispecific Engagers: Redefining Strategies Against Checkpoint ResistanceHeinz Läubli, David König, Marco Donia, et al.
Cancers|April 13, 2023
Circulating Tumor DNA in Head and Neck Squamous Cell CarcinomaAnna Brandt, Benjamin Thiele, Christoph Schultheiß, et al.
Frontiers in Oncology|October 12, 2020
Targeting the Mutational Landscape of Bystander Cells: Drug-Promoted Blood Cancer From High-Prevalence Pre-neoplasias in Patients on BRAF InhibitorsDonjete Simnica, Harald Ittrich, Carsten Bockemeyer, et al.
Pageof 17